Mead Johnson Nutrition Company (MJN) has a market cap of $13.9 billion. It rose 5.3% to close at $75.25 per share on January 18, 2017. The stock’s weekly, monthly, and year-to-date (or YTD) price movements were 5.8%, 5.2%, and 6.4%, respectively, on the same day.
MJN is trading 5.6% above its 20-day moving average, 5.1% above its 50-day moving average, and 6.2% below its 200-day moving average.
Related ETF and peers
The market caps of MJN’s competitors are as follows:
On January 18, 2017, Berenberg initiated its coverage of Mead Johnson Nutrition Company (MJN) with a “sell” rating, Berenberg set the stock’s price target at $66.00 per share.
Mead Johnson’s performance in 3Q16
Mead Johnson Nutrition (MJN) reported 3Q16 net sales of $937.5 million, which is a YoY (year-over-year) fall of 4.1% from its net sales of $977.5 million in 3Q15. Sales from Asia, Latin America, and North America and Europe fell 2.9%, 13.0%, and 0.79%, respectively, between 3Q15 and 3Q16.
The company’s gross profit margin narrowed 10 basis points and its EBIT[1. earnings before interest and tax] grew 120 basis points.
Its net income fell to $149.3 million and its EPS (earnings per share) rose to $0.80 in 3Q16, compared with $155.2 million and $0.77, respectively, in 3Q15. It reported non-GAAP[2. generally accepted accounting principles] EPS of $0.87 in 3Q16, a rise of 8.7% over 3Q15.
MJN’s cash and cash equivalents rose 8.3%, and its inventories fell 1.8% between 4Q15 and 3Q16.
Mead Johnson Nutrition (MJN) made the following projections for fiscal 2016:
- sales 2%–3% lower than 2015 on a constant dollar basis, or 6%–7% lower on a reported basis
- GAAP EPS in the range of $2.80–$2.87
- non-GAAP EPS in the range of $3.43–$3.50
Next, we’ll look at Deckers Outdoor Corporation (DECK).